DSI
PFE icon

Daiwa SB Investments’s Pfizer PFE Stock Holding History

Daiwa SB Investments’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$361K Sell
8,948
-1,539
-15% -$61.6K 0.07% 101
2018
Q4 		$434K Buy
10,487
+9,338
+813% +$388K 0.1% 98
2018
Q3 		$48K Sell
1,149
-9,707
-89% -$374K 0.01% 182
2018
Q2 		$374K Buy
10,856
+2,856
+36% +$97.6K 0.09% 111
2018
Q1 		$269K Sell
8,000
-1,001
-11% -$34.4K 0.08% 114
2017
Q4 		$309K Hold
9,001
– – 0.08% 117
2017
Q3 		$305K Buy
9,001
+1,813
+25% +$58.3K 0.08% 105
2017
Q2 		$229K Sell
7,188
-833
-10% -$26.3K 0.06% 119
2017
Q1 		$260K Sell
8,021
-548
-6% -$17.3K 0.07% 117
2016
Q4 		$264K Buy
8,569
+611
+8% +$18.7K 0.07% 117
2016
Q3 		$256K Sell
7,958
-917
-10% -$30.7K 0.07% 120
2016
Q2 		$295K Sell
8,875
-7,736
-47% -$247K 0.09% 89
2016
Q1 		$467K Sell
16,611
-24,378
-59% -$696K 0.12% 88
2015
Q4 		$1.25M Sell
40,989
-228,861
-85% -$7.2M 0.29% 70
2015
Q3 		$8.04M Buy
269,850
+5,890
+2% +$189K 1.84% 23
2015
Q2 		$8.4M Sell
263,960
-3,193
-1% -$104K 1.63% 20
2015
Q1 		$8.82M Sell
267,153
-194,243
-42% -$6.18M 1.58% 23
2014
Q4 		$13.6M Sell
461,396
-15,284
-3% -$438K 2.18% 6
2014
Q3 		$13.4M Buy
476,680
+355,156
+292% +$9.97M 1.67% 12
2014
Q2 		$3.42M Sell
121,524
-4,885
-4% -$139K 0.43% 66
2014
Q1 		$3.85M Sell
126,409
-13,255
-9% -$395K 0.46% 40
2013
Q4 		$4.06M Sell
139,664
-4,427
-3% -$129K 0.45% 38
2013
Q3 		$3.93M Sell
144,091
-3,299
-2% -$89.8K 0.45% 41
2013
Q2 		$3.92M Buy
+147,390
New +$4.07M 0.66% 39

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Daiwa SB Investments's PFE Position: Q1 2019 in Review

Daiwa SB Investments reduced its Pfizer (PFE) stake by 15% in Q1 2019, selling an estimated $61.6K and leaving 8,948 shares worth $361K. The position accounts for 0.07% of the portfolio, ranked #101.

Daiwa SB Investments first reported a position in PFE in Q2 2013 and has held it in 24 quarters since. The position peaked at $13.6M in Q4 2014. 2,391 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

  • Daiwa SB Investments held 8,948 shares of Pfizer worth $361K as of Q1 2019.
  • Daiwa SB Investments sold 1,539 Pfizer shares in Q1 2019, an estimated $61.6K.
  • Pfizer made up 0.07% of Daiwa SB Investments's portfolio in Q1 2019, its #101 holding.
  • Daiwa SB Investments first reported a position in Pfizer in Q2 2013 and has held it in 24 quarters since.
  • Daiwa SB Investments's Pfizer position peaked at $13.6M in Q4 2014.
  • 2,391 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on Daiwa SB Investments's 13F filing for Q1 2019, filed 18 Apr 2019.